{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:43:08Z","timestamp":1771263788703,"version":"3.50.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T00:00:00Z","timestamp":1413936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanopart Res"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s11051-014-2602-0","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T04:50:47Z","timestamp":1413953447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sustainable strategies for nano-in-micro particle engineering for pulmonary delivery"],"prefix":"10.1007","volume":"16","author":[{"given":"A. Sofia","family":"Silva","sequence":"first","affiliation":[]},{"given":"M\u00e1rcia T.","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Aguiar-Ricardo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"2602_CR1","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/bit.22470","volume":"104","author":"R Adami","year":"2009","unstructured":"Adami R, Oss\u00e9o LS, Reverchon E (2009) Micronization of lysozyme by supercritical assisted atomization. Biotechnol Bioeng 104:1162\u20131170","journal-title":"Biotechnol Bioeng"},{"key":"2602_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cej.2011.07.036","volume":"173","author":"R Adami","year":"2011","unstructured":"Adami R, Liparoti S, Reverchon E (2011) A new supercritical assisted atomization configuration, for the micronization of thermolabile compounds. Chem Eng J 173:55\u201361","journal-title":"Chem Eng J"},{"key":"2602_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jconrel.2009.06.006","volume":"139","author":"Y Akiyama","year":"2009","unstructured":"Akiyama Y, Mori T, Katayama Y, Niidome T (2009) The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. J Control Release 139:81\u201384","journal-title":"J Control Release"},{"key":"2602_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/jps.10352","volume":"92","author":"G Alderborn","year":"2003","unstructured":"Alderborn G, Elofsson U, Elversson J, Millqvist-fureby A (2003) Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J Pharm Sci 92:900\u2013910","journal-title":"J Pharm Sci"},{"key":"2602_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jconrel.2011.08.008","volume":"157","author":"S Al-Qadi","year":"2012","unstructured":"Al-Qadi S, Grenha A, Carri\u00f3n Recio D, Seijo B, Remu\u00f1\u00e1n-L\u00f3pez C (2012) Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations. J Control Release 157:383\u2013390","journal-title":"J Control Release"},{"key":"2602_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejpb.2007.05.007","volume":"68","author":"M Amidi","year":"2008","unstructured":"Amidi M, Pellikaan HC, de Boer AH, Crommelin DJA, Hennink WE, Jiskoot W (2008) Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur J Pharm Biopharm 68:191\u2013200","journal-title":"Eur J Pharm Biopharm"},{"key":"2602_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1166\/jnn.2004.081","volume":"4","author":"PJA Borm","year":"2004","unstructured":"Borm PJA, Kreyling W (2004) Toxicological hazards of inhaled nanoparticles\u2014potential implications for drug delivery. J Nanosci Nanotechnol 4:521\u2013531","journal-title":"J Nanosci Nanotechnol"},{"key":"2602_CR8","unstructured":"Cabral RP (2013) Development of chitosan-based microparticles for pulmonary drug delivery. Dissertation, Univerdade Nova de Lisboa"},{"key":"2602_CR9","unstructured":"Casimiro T, Barroso T, Figueiredo P, Costa E, Aguiar-Ricardo A (2011) Porous chitosan \u2013drug formulations by scCO2-assisted atomization. In: Proceedings of 13th European meeting on supercritical fluids. http:\/\/www.isasf.net\/fileadmin\/files\/Docs\/DenHaag\/HtmlDir\/Papers\/P68.pdf. Accessed 20 May 2014"},{"key":"2602_CR10","unstructured":"Challoner P, Rodriguez C, Tarara T (2012) Tobramycin formulation for treatment of endobronchial infections European Patent 1765288 B1"},{"key":"2602_CR11","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1021\/ie010040r","volume":"40","author":"P Chattopadhyay","year":"2001","unstructured":"Chattopadhyay P, Gupta RB (2001) Production of antibiotic nanoparticles using supercritical CO2 as antisolvent with enhanced mass transfer. Ind Eng Chem Res 40:3530\u20133539","journal-title":"Ind Eng Chem Res"},{"key":"2602_CR12","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1021\/ie020205b","volume":"41","author":"P Chattopadhyay","year":"2002","unstructured":"Chattopadhyay P, Gupta RB (2002) Supercritical CO2 based production of magnetically responsive micro- and nanoparticles for drug targeting. Ind Eng Chem Res 41:6049\u20136058","journal-title":"Ind Eng Chem Res"},{"key":"2602_CR13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/nbt.1696","volume":"28","author":"HS Choi","year":"2010","unstructured":"Choi HS, Ashitate Y, Lee JH, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 28:1300\u20131303","journal-title":"Nat Biotechnol"},{"key":"2602_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","volume":"24","author":"AHL Chow","year":"2007","unstructured":"Chow AHL, Tong HHY, Chattopadhyay P, Shekunov BY (2007) Particle engineering for pulmonary drug delivery. Pharm Res 24:411\u2013437","journal-title":"Pharm Res"},{"key":"2602_CR104","unstructured":"ClinicalTrials.gov (2013) A clinical trial to assess the safety of a measles vaccine (dry powder) administered by two different devices (PMV-001). http:\/\/clinicaltrials.gov\/show\/NCT01557699. Accessed 14 Oct 2014"},{"key":"2602_CR105","unstructured":"ClinicalTrials.gov (2014) Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis (Non-CF BE) (RESPIRE 1). http:\/\/clinicaltrials.gov\/show\/NCT01764841. Accessed 14 Oct 2014"},{"issue":"20","key":"2602_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel J (2013) Cancer immunotherapy. Science 342(20):1432\u20131433","journal-title":"Science"},{"key":"2602_CR16","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1164\/ajrccm.160.5.9810080","volume":"160","author":"NR Crowther Labiris","year":"1999","unstructured":"Crowther Labiris NR, Holbrook AM, Chrystyn H et al (1999) Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study. Am J Respir Crit Care Med 160:1711\u20131716","journal-title":"Am J Respir Crit Care Med"},{"key":"2602_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jconrel.2010.02.013","volume":"144","author":"LJ Cruz","year":"2010","unstructured":"Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, Figdor CG (2010) Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. J Control Release 144:118\u2013126","journal-title":"J Control Release"},{"key":"2602_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.addr.2007.08.023","volume":"59","author":"S-A Cryan","year":"2007","unstructured":"Cryan S-A, Sivadas N, Garcia-Contreras L (2007) In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev 59:1133\u20131151","journal-title":"Adv Drug Deliv Rev"},{"key":"2602_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4155\/tde.12.21","volume":"3","author":"EC Dreaden","year":"2012","unstructured":"Dreaden EC, Austin LA, Mackey MA, El-Sayed MA (2012) Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv 3:457\u2013478","journal-title":"Ther Deliv"},{"key":"2602_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3109\/10837459809028624","volume":"3","author":"CA Dunbar","year":"1998","unstructured":"Dunbar CA, Concessio NM, Anthony J (1998) Evaluation of atomizer performance in production. Pharm Dev Technol 3:433\u2013441","journal-title":"Pharm Dev Technol"},{"key":"2602_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2010.06.004","volume":"148","author":"B Duncan","year":"2010","unstructured":"Duncan B, Kim C, Rotello VM (2010) Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release 148:122\u2013127","journal-title":"J Control Release"},{"key":"2602_CR22","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jps.20418","volume":"94","author":"J Elversson","year":"2005","unstructured":"Elversson J, Millqvist-Fureby A (2005) Particle size and density in spray drying-effects of carbohydrate properties. J Pharm Sci 94:2049\u20132060","journal-title":"J Pharm Sci"},{"key":"2602_CR23","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1210\/jc.2004-2229","volume":"90","author":"SE Fineberg","year":"2005","unstructured":"Fineberg SE, Kawabata T, Finco-Kent D, Liu C, Krasner A (2005) Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. J Clin Endocrinol Metab 90:3287\u20133294","journal-title":"J Clin Endocrinol Metab"},{"key":"2602_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-5173(99)00133-7","volume":"186","author":"BJ Gabrio","year":"1999","unstructured":"Gabrio BJ, Stein SW, Velasquez DJ (1999) A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers. Int J Pharm 186:3\u201312","journal-title":"Int J Pharm"},{"key":"2602_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1743-8977-10-19","volume":"10","author":"M Geiser","year":"2013","unstructured":"Geiser M, Quaile O, Wenk A, Wigge C, Eigeldinger-Berthou S, Hirn S, Sch\u00e4ffler M, Schleh C, M\u00f6ller W, Mall MA, Kreyling WG (2013) Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease. Part Fibre Toxicol 10:19\u201329","journal-title":"Part Fibre Toxicol"},{"key":"2602_CR26","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1208\/s12249-010-9462-4","volume":"11","author":"N Genina","year":"2010","unstructured":"Genina N, R\u00e4ikk\u00f6nen H, Hein\u00e4m\u00e4ki J, Veski P, Yliruusi J (2010) Nano-coating of \u03b2-galactosidase onto the surface of lactose by using an ultrasound-assisted technique. AAPS PharmSciTech 11:959\u2013965","journal-title":"AAPS PharmSciTech"},{"key":"2602_CR27","first-page":"18","volume":"28","author":"M Gil","year":"2010","unstructured":"Gil M, Vicente J, Gaspar F (2010) Scale-up methodology for pharmaceutical spray drying. Chem Today 28:18\u201322","journal-title":"Chem Today"},{"key":"2602_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/10837450.2012.726998","volume":"18","author":"P Girotra","year":"2013","unstructured":"Girotra P, Singh SK, Nagpal K (2013) Supercritical fluid technology: a promising approach in pharmaceutical research. Pharm Dev Technol 18:22\u201338","journal-title":"Pharm Dev Technol"},{"key":"2602_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jconrel.2008.02.008","volume":"128","author":"C G\u00f3mez-Gaete","year":"2008","unstructured":"G\u00f3mez-Gaete C, Fattal E, Silva L, Besnard M, Tsapis N (2008) Dexamethasone acetate encapsulation into Trojan particles. J Control Release 128:41\u201349","journal-title":"J Control Release"},{"key":"2602_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejpb.2007.10.017","volume":"69","author":"A Grenha","year":"2008","unstructured":"Grenha A, Remu\u00f1\u00e1n-L\u00f3pez C, Carvalho ELS, Seijo B (2008) Microspheres containing lipid\/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur J Pharm Biopharm 69:83\u201393","journal-title":"Eur J Pharm Biopharm"},{"key":"2602_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijpharm.2007.03.035","volume":"341","author":"K Hadinoto","year":"2007","unstructured":"Hadinoto K, Zhu K, Tan RBH (2007) Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery. Int J Pharm 341:195\u2013206","journal-title":"Int J Pharm"},{"key":"2602_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200039010-00001","volume":"39","author":"JG Hardy","year":"2000","unstructured":"Hardy JG, Chadwick TS (2000) Sustained release drug delivery to the lungs: an option for the future. Clin Pharmacokinet 39:1\u20134","journal-title":"Clin Pharmacokinet"},{"key":"2602_CR33","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jps.20916","volume":"96","author":"AJ Hickey","year":"2007","unstructured":"Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T, McLean R, Langridge J, Papadopoulos D (2007) Physical characterization of component particles included in dry powder inhalers I. Strategy review and static characteristics. J Pharm Sci 96:1282\u20131301","journal-title":"J Pharm Sci"},{"key":"2602_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-3155-2-12","volume":"2","author":"PH Hoet","year":"2004","unstructured":"Hoet PH, Br\u00fcske-Hohlfeld I, Salata OV (2004) Nanoparticles\u2014known and unknown health risks. J Nanobiotechnol 2:12\u201327","journal-title":"J Nanobiotechnol"},{"key":"2602_CR35","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1007\/s11051-013-1560-2","volume":"15","author":"J Hu","year":"2013","unstructured":"Hu J, Dong Y, Pastorin G, Ng WK, Tan RBH (2013) Spherical agglomerates of pure drug nanoparticles for improved pulmonary delivery in dry powder inhalers. J Nanoparticle Res 15:1560\u20131572","journal-title":"J Nanoparticle Res"},{"key":"2602_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"Sk Lai","year":"2010","unstructured":"Lai Sk, Wang Y-Y, Hanes J (2010) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 61:158\u2013171","journal-title":"Adv Drug Deliv Rev."},{"key":"2602_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10731199.2011.592494","volume":"40","author":"G Kaur","year":"2012","unstructured":"Kaur G, Narang RK, Rath G, Goyal AK (2012) Advances in pulmonary delivery of nanoparticles. Artif Cells Blood Substit Immobil Biotechnol 40:75\u201396","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"2602_CR38","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1002\/jps.21673","volume":"98","author":"SR Kaye","year":"2009","unstructured":"Kaye SR, Tol SP, Alpar HO (2009) Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies. J Pharm Sci 98:4055\u20134068","journal-title":"J Pharm Sci"},{"key":"2602_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nbt0508-479","volume":"26","author":"J Kling","year":"2008","unstructured":"Kling J (2008) Inhaled insulin\u2019s last gasp? Nat Biotechnol 26:479\u2013480","journal-title":"Nat Biotechnol"},{"key":"2602_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijpharm.2009.05.008","volume":"377","author":"C Klingler","year":"2009","unstructured":"Klingler C, M\u00fcller BW, Steckel H (2009) Insulin-micro- and nanoparticles for pulmonary delivery. Int J Pharm 377:173\u2013179","journal-title":"Int J Pharm"},{"key":"2602_CR41","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1023\/B:PHAM.0000032997.96823.88","volume":"21","author":"K Koushik","year":"2004","unstructured":"Koushik K, Dhanda DS, Cheruvu NPS, Kompella UB (2004) Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm Res 21:1119\u20131126","journal-title":"Pharm Res"},{"key":"2602_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1517\/17425247.2010.492212","volume":"7","author":"BD Kurmi","year":"2010","unstructured":"Kurmi BD, Kayat J, Gajbhiye V, Tekade RK (2010) Micro- and nanocarrier-mediated lung targeting. Expert Opin Drug Deliv 7:781\u2013794","journal-title":"Expert Opin Drug Deliv"},{"key":"2602_CR43","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0091-6749(98)70376-8","volume":"101","author":"BL Laube","year":"1998","unstructured":"Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS (1998) Respiratory pathophysiologic responses: the efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 101:475\u2013483","journal-title":"J Allergy Clin Immunol"},{"key":"2602_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11095-006-0027-x","volume":"23","author":"H-Y Li","year":"2006","unstructured":"Li H-Y, Birchall J (2006) Chitosan-modified dry powder formulations for pulmonary gene delivery. Pharm Res 23:941\u2013950","journal-title":"Pharm Res"},{"key":"2602_CR45","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s11095-010-0201-z","volume":"27","author":"Y-Z Li","year":"2010","unstructured":"Li Y-Z, Sun X, Gong T, Liu J, Zuo J, Zhang ZR (2010) Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles. Pharm Res 27:1977\u20131986","journal-title":"Pharm Res"},{"key":"2602_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.powtec.2005.04.035","volume":"158","author":"M Linsenb\u00fchler","year":"2005","unstructured":"Linsenb\u00fchler M, Wirth K-E (2005) An innovative dry powder coating process in non-polar liquids producing tailor-made micro-particles. Powder Technol 158:3\u201320","journal-title":"Powder Technol"},{"key":"2602_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 3:1377\u20131397","journal-title":"Polymers (Basel)"},{"key":"2602_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1461-5347(98)00099-6","volume":"1","author":"RJ Malcolmson","year":"1998","unstructured":"Malcolmson RJ, Embleton JK (1998) Dry powder formulations for pulmonary delivery. Pharm Sci Technolo Today 1:394\u2013398","journal-title":"Pharm Sci Technolo Today"},{"key":"2602_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/IJN.S4937","volume":"4","author":"HM Mansour","year":"2009","unstructured":"Mansour HM, Rhee Y-S, Wu X (2009) Nanomedicine in pulmonary delivery. Int J Nanomed 4:299\u2013319","journal-title":"Int J Nanomed"},{"key":"2602_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.addr.2007.06.019","volume":"60","author":"A Mart\u00edn","year":"2008","unstructured":"Mart\u00edn A, Cocero MJ (2008) Micronization processes with supercritical fluids: fundamentals and mechanisms. Adv Drug Deliv Rev 60:339\u2013350","journal-title":"Adv Drug Deliv Rev"},{"key":"2602_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.supflu.2010.08.008","volume":"55","author":"\u00c1 Mart\u00edn","year":"2010","unstructured":"Mart\u00edn \u00c1, Weidner E (2010) PGSS-drying: mechanisms and modeling. J Supercrit Fluids 55:271\u2013281","journal-title":"J Supercrit Fluids"},{"key":"2602_CR52","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cep.2010.09.014","volume":"49","author":"\u00c1 Mart\u00edn","year":"2010","unstructured":"Mart\u00edn \u00c1, Pham HM, Kilzer A, Kareth S, Weidner E (2010) Micronization of polyethylene glycol by PGSS (Particles from Gas Saturated Solutions)-drying of aqueous solutions. Chem Eng Process Process Intensif 49:1259\u20131266","journal-title":"Chem Eng Process Process Intensif"},{"key":"2602_CR53","unstructured":"McGlynn P, Bakale R, Sturge C (2007) Levalbuterol salt US Patent 7256310 B2 10"},{"key":"2602_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0378-5173(99)00226-4","volume":"188","author":"A Millqvist-fureby","year":"1999","unstructured":"Millqvist-fureby A, Malmsten M (1999) Spray-drying of trypsin\u2014surface characterisation and activity preservation. Int J Pharm 188:243\u2013253","journal-title":"Int J Pharm"},{"key":"2602_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tube.2010.08.009","volume":"91","author":"A Misra","year":"2011","unstructured":"Misra A, Hickey AJ, Rossi C, Borchard G, Terada H, Makino K, Fourie PB, Colombo P (2011) Inhaled drug therapy for treatment of tuberculosis. Tuberculosis 91:71\u201381","journal-title":"Tuberculosis"},{"key":"2602_CR56","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.powtec.2013.02.025","volume":"239","author":"PH Moghaddam","year":"2013","unstructured":"Moghaddam PH, Ramezani V, Esfandi E, Vatanara A, Nabi-Meiobodi M, Darabi M, Gilani K, Najafabadi AR (2013) Development of a nano\u2013micro carrier system for sustained pulmonary delivery of clarithromycin. Powder Technol 239:478\u2013483","journal-title":"Powder Technol"},{"key":"2602_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ijpharm.2011.11.014","volume":"423","author":"N Mohajel","year":"2012","unstructured":"Mohajel N, Najafabadi AR, Azadmanesh K, Vatanara A, Moazeni E, Rahimi A, Gilani K (2012) Optimization of a spray drying process to prepare dry powder microparticles containing plasmid nanocomplex. Int J Pharm 423:577\u2013585","journal-title":"Int J Pharm"},{"key":"2602_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(98)00029-5","volume":"170","author":"SP Newman","year":"1998","unstructured":"Newman SP, Wilding IR (1998) Gamma scintigraphy: an in vivo technique for assessing the equivalence of inhaled products. Int J Pharm 170:1\u20139","journal-title":"Int J Pharm"},{"key":"2602_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijpharm.2010.11.040","volume":"405","author":"LM Nolan","year":"2011","unstructured":"Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM (2011) Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglycate. Int J Pharm 405:36\u201346","journal-title":"Int J Pharm"},{"key":"2602_CR60","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1289\/ehp.7339","volume":"113","author":"G Oberd\u00f6rster","year":"2005","unstructured":"Oberd\u00f6rster G, Oberd\u00f6rster E, Oberd\u00f6rster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823\u2013839","journal-title":"Environ Health Perspect"},{"key":"2602_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijpharm.2012.04.067","volume":"433","author":"M Odziomek","year":"2012","unstructured":"Odziomek M, Sosnowski TR, Grado\u0144 L (2012) Conception, preparation and properties of functional carrier particles for pulmonary drug delivery. Int J Pharm 433:51\u201359","journal-title":"Int J Pharm"},{"key":"2602_CR62","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/adfm.200801164","volume":"19","author":"M Oishi","year":"2009","unstructured":"Oishi M, Tamura A, Nakamura T, Nagasaki Y (2009) A smart nanoprobe based on fluorescence-quenching PEGylated nanogels containing gold nanoparticles for monitoring the response to cancer therapy. Adv Funct Mater 19:827\u2013834","journal-title":"Adv Funct Mater"},{"key":"2602_CR63","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jps.10285","volume":"92","author":"H Okamoto","year":"2003","unstructured":"Okamoto H, Nishida S, Todo H, Sakakur Y, Iida K, Danjo K (2003) Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process. J Pharm Sci 92:371\u2013380","journal-title":"J Pharm Sci"},{"key":"2602_CR64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11095-005-8718-2","volume":"23","author":"T Ozeki","year":"2006","unstructured":"Ozeki T, Beppu S, Mizoe T, Takashima Y, Yuasa H, Okada H (2006) Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier. Pharm Res 23:177\u2013183","journal-title":"Pharm Res"},{"key":"2602_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11095-008-9714-0","volume":"26","author":"CB Packhaeuser","year":"2009","unstructured":"Packhaeuser CB, Lahnstein K, Sitterberg J, Schmehl T, Gessler T, Bakowsky U, Seeger W, Kissel T (2009) Stabilization of aerosolizable nano-carriers by freeze-drying. Pharm Res 26:129\u2013138","journal-title":"Pharm Res"},{"key":"2602_CR66","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ejps.2005.11.007","volume":"27","author":"I Pasquali","year":"2006","unstructured":"Pasquali I, Bettini R, Giordano F (2006) Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur J Pharm Sci 27:299\u2013310","journal-title":"Eur J Pharm Sci"},{"key":"2602_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","volume":"392","author":"G Pilcer","year":"2010","unstructured":"Pilcer G, Amighi K (2010) Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 392:1\u201319","journal-title":"Int J Pharm"},{"key":"2602_CR68","first-page":"16","volume":"105","author":"MC Powell","year":"2006","unstructured":"Powell MC, Kanarek MS (2006) Nanomaterial health effects\u2014part 1: background and current knowledge. Wis Med J 105:16\u201320","journal-title":"Wis Med J"},{"key":"2602_CR69","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1517\/17425247.4.6.651","volume":"4","author":"B Pulliam","year":"2007","unstructured":"Pulliam B, Sung JC, Edwards DA (2007) Design of nanoparticle-based dry powder pulmonary vaccines. Expert Opin Drug Deliv 4:651\u2013663","journal-title":"Expert Opin Drug Deliv"},{"key":"2602_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2004.02.001","volume":"22","author":"M Rehman","year":"2004","unstructured":"Rehman M, Shekunov BY, York P, Lechuga-Ballesteros D, Miller DP, Tan T, Colthorpe P (2004) Optimisation of powders for pulmonary delivery using supercritical fluid technology. Eur J Pharm Sci 22:1\u201317","journal-title":"Eur J Pharm Sci"},{"key":"2602_CR106","doi-asserted-by":"publisher","unstructured":"Restani RB, Conde J, Baptista PV, Cidade MT, Bragan\u00e7a AM, Morgado J, Correia I, Aguiar-Ricardo A, Bonif\u00e1cio VDB (2014) Polyurea dendrimer for efficient cytosolic siRNA\u00a0delivery. RSC Adv. doi:10.1039\/C4RA0903G","DOI":"10.1039\/C4RA0903G"},{"key":"2602_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0896-8446(98)00129-6","volume":"15","author":"E Reverchon","year":"1999","unstructured":"Reverchon E (1999) Supercritical antisolvent precipitation of micro- and nano-particles. J Supercrit Fluids 15:1\u201321","journal-title":"J Supercrit Fluids"},{"key":"2602_CR72","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1021\/ie010943k","volume":"41","author":"E Reverchon","year":"2002","unstructured":"Reverchon E (2002) Supercritical-assisted atomization to produce micro- and\/or nanoparticles of controlled size and distribution. Ind Eng Chem Res 41:2405\u20132411","journal-title":"Ind Eng Chem Res"},{"key":"2602_CR73","unstructured":"Reverchon E (2007) Process for the production of micro and\/or nano particles US Patent 7276190 B2. 10"},{"key":"2602_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.supflu.2005.08.003","volume":"37","author":"E Reverchon","year":"2006","unstructured":"Reverchon E, Adami R (2006) Nanomaterials and supercritical fluids. J Supercrit Fluids 37:1\u201322","journal-title":"J Supercrit Fluids"},{"key":"2602_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.supflu.2006.01.017","volume":"37","author":"E Reverchon","year":"2006","unstructured":"Reverchon E, Adami R, Caputo G (2006) Supercritical assisted atomization: Performance comparison between laboratory and pilot scale. J Supercrit Fluids 37:298\u2013306","journal-title":"J Supercrit Fluids"},{"key":"2602_CR76","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1517\/17425247.4.6.607","volume":"6","author":"PG Rogueda","year":"2007","unstructured":"Rogueda PG, Traini D (2007) The nanoscale in pulmonary delivery. Part 2: formulation platforms. Expert Opin Drug Deliv 6:607\u2013620","journal-title":"Expert Opin Drug Deliv"},{"key":"2602_CR77","volume-title":"Handbook of pharmaceutical excipients","author":"RC Rowe","year":"2009","unstructured":"Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients. Pharmaceutical Press, London"},{"key":"2602_CR78","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1016\/j.biomaterials.2013.03.061","volume":"34","author":"T Sadhukha","year":"2013","unstructured":"Sadhukha T, Wiedmann TS, Panyam J (2013) Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials 34:5163\u20135171","journal-title":"Biomaterials"},{"key":"2602_CR79","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.addr.2006.07.012","volume":"58","author":"M Sakagami","year":"2006","unstructured":"Sakagami M (2006) In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58:60\u20131030","journal-title":"Adv Drug Deliv Rev"},{"key":"2602_CR80","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s10853-011-6054-y","volume":"47","author":"D Sanli","year":"2011","unstructured":"Sanli D, Bozbag SE, Erkey C (2011) Synthesis of nanostructured materials using supercritical CO2: Part I. Physical transformations. J Mater Sci 47:2995\u20133025","journal-title":"J Mater Sci"},{"key":"2602_CR81","first-page":"861","volume":"7","author":"C Sinsuebpol","year":"2013","unstructured":"Sinsuebpol C, Chatchawalsaisin J, Kulvanich P (2013) Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Drug Des Devel Ther 7:861\u2013873","journal-title":"Drug Des Devel Ther"},{"key":"2602_CR82","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijpharm.2008.03.024","volume":"358","author":"N Sivadas","year":"2008","unstructured":"Sivadas N, O\u2019Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG, Hickey AJ, Cryan SA (2008) A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 358:159\u2013167","journal-title":"Int J Pharm"},{"key":"2602_CR83","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijpharm.2013.01.003","volume":"443","author":"Y-J Son","year":"2013","unstructured":"Son Y-J, Worth Longest P, Hindle M (2013) Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance. Int J Pharm 443:137\u2013145","journal-title":"Int J Pharm"},{"key":"2602_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejps.2012.10.021","volume":"48","author":"S Stegemann","year":"2013","unstructured":"Stegemann S, Kopp S, Borchard G, Shah VP, Senel S, Dubey R, Urbanetz N, Cittero M, Schoubben A, Hippchen C, Cade D, Fuglsang A, Morais J, Borgstr\u00f6m L, Farshi F, Seyfang KH, Hermann R, van de Putte A, Klebovich I, Hincal A (2013) Developing and advancing dry powder inhalation towards enhanced therapeutics. Eur J Pharm Sci 48:181\u2013194","journal-title":"Eur J Pharm Sci"},{"key":"2602_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0169-409X(01)00099-0","volume":"48","author":"GA Stephenson","year":"2001","unstructured":"Stephenson GA, Forbes RA, Reutzel-Edens SM (2001) Characterization of the solid state: quantitative issues. Adv Drug Deliv Rev 48:67\u201390","journal-title":"Adv Drug Deliv Rev"},{"key":"2602_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/9780470656792","volume-title":"Solid state characterization of pharmaceuticals","author":"RA Storey","year":"2011","unstructured":"Storey RA, Ingvar Y (2011) Solid state characterization of pharmaceuticals. Wiley, Hoboken"},{"key":"2602_CR87","first-page":"55","volume":"26","author":"JC Sung","year":"2009","unstructured":"Sung JC, Padilla DJ, Garcia-Contreras L, Verberkmoes JL, Durbin D, Peloquin CA, Elbert KJ, Hickey AJ, Edwards DA (2009) Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 26:55\u20131847","journal-title":"Pharm Res"},{"key":"2602_CR88","first-page":"1209","volume":"50","author":"MJ Telko","year":"2005","unstructured":"Telko MJ, Dsc AJH (2005) Dry powder inhaler formulation. Respir Care 50:1209\u20131227","journal-title":"Respir Care"},{"key":"2602_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.06.025","volume":"325","author":"P Tewa-Tagne","year":"2006","unstructured":"Tewa-Tagne P, Brian\u00e7on S, Fessi H (2006) Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics. Int J Pharm 325:63\u201374","journal-title":"Int J Pharm"},{"key":"2602_CR90","unstructured":"Ticehurst M, Marziano I, Kougoulos E (2014) Process for the preparation of fluticasone propionate form 1 US Patent 0141247 A1 14"},{"key":"2602_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03639040903092319","volume":"36","author":"JA Tolman","year":"2010","unstructured":"Tolman JA, Williams RO (2010) Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties. Drug Dev Ind Pharm 36:1\u201330","journal-title":"Drug Dev Ind Pharm"},{"key":"2602_CR107","doi-asserted-by":"crossref","unstructured":"Tonnis WF, Lexmond AJ, Frijlink HW, de Boer AH, Hinrichs WLJ (2013) Devices and formulations for pulmonary vaccination. Expert Opin Drug Deliv 10:1383\u20131397","DOI":"10.1517\/17425247.2013.810622"},{"key":"2602_CR92","doi-asserted-by":"publisher","first-page":"12001","DOI":"10.1073\/pnas.182233999","volume":"99","author":"N Tsapis","year":"2002","unstructured":"Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA (2002) Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci USA 99:12001\u201312005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2602_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0896-8446(98)00131-4","volume":"15","author":"M T\u00fcrk","year":"1999","unstructured":"T\u00fcrk M (1999) Formation of small organic particles by RESS : experimental and theoretical investigations. J Supercrit Fluids 15:79\u201389","journal-title":"J Supercrit Fluids"},{"key":"2602_CR94","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.2042-7158.2012.01486.x","volume":"64","author":"F Ungaro","year":"2012","unstructured":"Ungaro F, D\u2019Angelo I, Miro A, La Rotonda MI, Quaglia F (2012) Engineered PLGA nano-and micro-carriers for pulmonary delivery: challenges and promises. J Pharm Pharmacol 64:1217\u20131235","journal-title":"J Pharm Pharmacol"},{"key":"2602_CR95","volume-title":"Peptide and protein delivery","author":"C Van Der Walle","year":"2011","unstructured":"Van Der Walle C (2011) Peptide and protein delivery. Elsevier, Oxford"},{"key":"2602_CR96","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","volume":"25","author":"R Vehring","year":"2008","unstructured":"Vehring R (2008) Pharmaceutical particle engineering via spray drying. Pharm Res 25:999\u20131022","journal-title":"Pharm Res"},{"key":"2602_CR97","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jconrel.2012.07.026","volume":"162","author":"P Wanakule","year":"2012","unstructured":"Wanakule P, Liu GW, Fleury AT, Roy K (2012) Nano-inside-micro: disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung. J Control Release 162:429\u2013437","journal-title":"J Control Release"},{"key":"2602_CR98","unstructured":"Weers J, Rao N, Huang D, Miller D, Tarara T (2013) Dry powder formulation of particles that contain two or more active ingridients for treating obstructive or inflammatory airways diseases US Patent 0319411 A1 13"},{"key":"2602_CR99","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.02.011","volume":"356","author":"W Yang","year":"2008","unstructured":"Yang W, Peters JI, Williams RO (2008) Inhaled nanoparticles\u2013a current review. Int J Pharm 356:239\u2013247","journal-title":"Int J Pharm"},{"key":"2602_CR100","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.biomaterials.2008.12.044","volume":"30","author":"Y Yang","year":"2009","unstructured":"Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y (2009) Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 30:1947\u20131953","journal-title":"Biomaterials"},{"key":"2602_CR101","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpharm.2013.04.077","volume":"451","author":"L Yang","year":"2013","unstructured":"Yang L, Luo J, Shi S, Zhang Q, Sun X, Zhang Z, Gong T (2013) Development of a pulmonary peptide delivery system using porous nanoparticle-aggregate particles for systemic application. Int J Pharm 451:104\u2013111","journal-title":"Int J Pharm"},{"key":"2602_CR102","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.supflu.2004.10.006","volume":"34","author":"S-D Yeo","year":"2005","unstructured":"Yeo S-D, Kiran E (2005) Formation of polymer particles with supercritical fluids: a review. J Supercrit Fluids 34:287\u2013308","journal-title":"J Supercrit Fluids"},{"key":"2602_CR103","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.addr.2010.11.002","volume":"63","author":"J Zhang","year":"2011","unstructured":"Zhang J, Wu L, Chan H-K, Watanabe W (2011) Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev 63:441\u2013455","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Nanoparticle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11051-014-2602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11051-014-2602-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11051-014-2602-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11051-014-2602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:03:48Z","timestamp":1684865028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11051-014-2602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":107,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2602"],"URL":"https:\/\/doi.org\/10.1007\/s11051-014-2602-0","relation":{},"ISSN":["1388-0764","1572-896X"],"issn-type":[{"value":"1388-0764","type":"print"},{"value":"1572-896X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]},"assertion":[{"value":"2 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2602"}}